Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Company News

Affibody, Asahi Kasei Corp. deal

November 7, 2005 8:00 AM UTC

The companies partnered to use Affibody's technology to develop an affinity ligand for an undisclosed target. The affinity ligand will be an Affibody molecule, which is a protein composed of a three-h...